Client Alert: COVID-19 and Emergency Medical Products: Immunity from Tort Litigation for Manufacturers and Distributors

As reported cases of COVID-19 continue to increase nationwide and worldwide, the need for emergency medical supplies and medical devices to combat this deadly virus becomes more urgent with each passing day. In an effort to support manufacturers and distributors of COVID-19-fighting drugs, biological products, or medical devices, the United States Department of Health and Human Services  published a Notice of Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19 in the Federal Register on March 17, 2020.